February 20, 2026
Safety
New
PMDA Risk Communications: Eplerenone etc. posted
February 20, 2026
Review
New
Evaluation Report on Applicability to Drug-agnostic Companion Diagnostics,posted
February 20, 2026
Int
New
PMDA-ATC Seminar Schedule FY2026 has been posted.
February 20, 2026
Other
New
Recent Publications by PMDA Staff updated
February 18, 2026
Review
New
List of Products Designated for Priority Review of SaMD updated
February 16, 2026
Review
New
English Translation of Review Report: Spikevax (Partial Change Approval)
February 16, 2026
Safety
New
PMDA Medical Safety Information: Precautions for Handling of Gastrostomy Catheters(No.72) posted
February 12, 2026
Review
One-Stop Service Platform by ENSEMBLExJ page created
February 10, 2026
Safety
MHLW Pharmaceuticals and Medical Devices Safety Information No.426 posted
February 10, 2026
Safety
Revisions of PRECAUTIONS: Cytarabine , etc. posted
February 6, 2026
JP
PDG October 2025 Meeting Highlights posted
February 20, 2026
Drug
IVD
New
Evaluation Report on Applicability to Drug-agnostic Companion Diagnostics,posted
February 18, 2026
Devices
New
List of Products Designated for Priority Review of SaMD updated
February 16, 2026
Drug
New
English Translation of Review Report: Spikevax (Partial Change Approval)
February 12, 2026
One-Stop Service Platform by ENSEMBLExJ page created
February 20, 2026
Drug
IVD
New
PMDA Risk Communications: Eplerenone etc. posted
February 16, 2026
All
New
PMDA Medical Safety Information: Precautions for Handling of Gastrostomy Catheters(No.72) posted
February 10, 2026
All
MHLW Pharmaceuticals and Medical Devices Safety Information No.426 posted
February 10, 2026
Drug
IVD
Revisions of PRECAUTIONS: Cytarabine , etc. posted
Currently, there is no applicable information.
Please note that this site may not be accurate due to machine translation, and all files (PDF, Excel, Word, PowerPoint) are not translated.